Please assess the completion status of the following clinical trial:

Trial Title: Vaccination Education Through Pharmacists and Senior Centers (VEPSC)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥50;~* Can attend a 2-hour session (though both PHARM and PEER entail 60 minutes of intervention, an additional hour is needed to allow for informed consent and data collection);~* Speak and read English at ≥4th grade level as determined by a brief reading passage;~* Cognitively intact as evidenced by an Abbreviated Mental Status Test score ≥7.~Exclusion Criteria:~* Failure to meet inclusion criteria~* Failure to give informed consent to participate in the study

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Pharmacist-led Intervention (PHARM) (Type: ACTIVE_COMPARATOR): In the PHARM intervention group, participants will be given a 60-minute formal presentation on vaccine-preventable diseases to address knowledge and beliefs related to zoster, pneumonia, and influenza and to address barriers to receiving vaccination. In several studies, it has been demonstrated that those who believe it is wise to receive vaccinations and those that have discussed vaccination with their healthcare provider are more likely to receive a vaccine.
- Peer-led Intervention (PEER) (Type: EXPERIMENTAL): A pharmacist will train the peer educators about vaccine-preventable diseases over the course of two didactic sessions. Following this training, a third session will be held to train the peer educators on the script that they will deliver to participants. The script will include the key learning points to be taught by the peer educators to participants about vaccine preventable diseases and vaccination. The script will also include role-play exercises. In the role-play exercises, 3 vaccination-related scenarios (one for each disease- zoster, pneumonia, and influenza) will be delivered to illustrate situations participants might encounter when interacting with healthcare providers or friends/family.

Based on this trial design, predict the completion outcome and termination type (if applicable).